Analysis of p53 Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia

No abstract is available for this paper.

• Publication year

  2012

• Venue

  DNA and Cell Biology

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/dna.2011.1314PMID 22047081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia.

  2011cited by this paper
• Priming and potentiation of DNA damage response by fibronectin in human colon cancer cells and tumor-derived myofibroblasts.

  2011cited by this paper
• Proapoptotic fibronectin fragment induces the degradation of ubiquitinated p53 via proteasomes in periodontal ligament cells.

  2010cited by this paper
• Anoikis triggers Mdm2-dependent p53 degradation

  2010cited by this paper
• A complex barcode underlies the heterogeneous response of p53 to stress

  2008cited by this paper
• New prognostic markers in chronic lymphocytic leukemia.

  2008cited by this paper
• The Proto-Oncogene LRF Is under Post-Transcriptional Control of MiR-20a: Implications for Senescence

  2008cited by this paper
• Chronic lymphocytic leukemia and treatment resistance in cancer: The role of the p53 pathway

  2008cited by this paper
• [Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia].

  2008cited by this paper
• Prognostic significance of combined analysis of ZAP‐70 and CD38 in chronic lymphocytic leukemia

  2007cited by this paper
• p53: Guardian of the Genome and Policeman of the Oncogenes

  2007cited by this paper
• Prognostic markers in chronic lymphocytic leukaemia.

  2007cited by this paper
• ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).

  2006cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Divorcing ARF and p53: an unsettled case

  2006cited by this paper
• Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling.

  2006cited by this paper
• In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.

  2005cited by this paper
• The transcription factor Pokemon: a new key player in cancer pathogenesis.

  2005cited by this paper
• p53: link to the past, bridge to the future.

  2005cited by this paper
• Role of the proto-oncogene Pokemon in cellular transformation and ARF repression

  2005cited by this paper
• Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.

  2005cited by this paper
• BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma.

  2005cited by this paper
• The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment

  2005cited by this paper
• Turning the key on p53

  2004cited by this paper
• The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

  2004influential reference
• Chronic lymphocytic leukemia: revelations from the B-cell receptor.

  2004cited by this paper
• Chronic lymphocytic leukemia : revelations from the B-cell receptor

  2004cited by this paper
• Essential role of Plzf in maintenance of spermatogonial stem cells

  2004cited by this paper
• Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survival.

  2003cited by this paper
• Altered expression of p53 and MDM2 proteins in hematological malignancies.

  2003cited by this paper
• p53 gene mutations are rare in human papillomavirus-associated colon cancer.

  2003cited by this paper
• Cell cycle regulatory functions of the human oncoprotein MDM2.

  2003cited by this paper
• Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses*

  2003cited by this paper
• Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course

  2002cited by this paper
• p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways.

  2002cited by this paper
• Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia

  2001cited by this paper
• Plzf regulates limb and axial skeletal patterning

  2000cited by this paper
• Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2

  1999cited by this paper
• Mutations in serines 15 and 20 of human p53 impair its apoptotic activity

  1999cited by this paper
• mdm2: a bridge over the two tumour suppressors, p53 and Rb

  1999cited by this paper
• Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.

  1998cited by this paper
• Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

  1998cited by this paper
• Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

  1998cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

  1997cited by this paper
• Expression profile of MDM‐2 proteins in chronic lymphocytic leukemia and their clinical relevance

  1997cited by this paper
• Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosis.

  1995cited by this paper
• The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.

  1994cited by this paper
• A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

  1981cited by this paper
• Clinical staging of chronic lymphocytic leukemia.

  1977cited by this paper
• Clinical staging of chronic lymphocytic leukemia.

  1975cited by this paper
• Chronic Lymphocytic Leukemia—An Accumulative Disorder of Immunologically Incompetent Lymphocytes.

  1967cited by this paper
• Special Article: Chronic Lymphocytic Leukemia—an Accumulative Disease of Immunologically Incompetent Lymphocytes

  1967cited by this paper

• СУЧАСНІ ПІДХОДИ ДО ДІАГНОСТИКИ ТА ПРОГНОЗУВАННЯ ПЕРЕБІГУ ХРОНІЧНОГО ЛІМФОЛЕЙКОЗУ

  2025cites this paper
• Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor.

  2020cites this paper
• P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia

  2016cites this paper
• The T309G Murine Double Minute 2 Gene Polymorphism Is an Independent Prognostic Factor for Patients with Renal Cell Carcinoma

  2015cites this paper
• Trichostatin A effectively induces apoptosis in chronic lymphocytic leukemia cells via inhibition of Wnt signaling and histone deacetylation

  2014cites this paper
• Differential Gene Expression Profiles of PPP2R5C-siRNA-Treated Malignant T Cells

  2013cites this paper